한빛사논문
Abstract
Shuibin Lin,1,2,5 Junho Choe,1,2,5 Peng Du,1,2 Robinson Triboulet,1,2 and Richard I. Gregory1,2,3,4,*
1Stem Cell Program, Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA 02115, USA
2Department of Biological Chemistry and Molecular Pharmacology
3Department of Pediatrics
Harvard Medical School, Boston, MA 02115, USA
4Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA
5Co-first author
*Correspondence: Richard I. Gregory
Summary
METTL3 is an RNA methyltransferase implicated in mRNA biogenesis, decay, and translation control through N6-methyladenosine (m6A) modification. Here we find that METTL3 promotes translation of certain mRNAs including epidermal growth factor receptor (EGFR) and the Hippo pathway effector TAZ in human cancer cells. In contrast to current models that invoke m6A reader proteins downstream of nuclear METTL3, we find METTL3 associates with ribosomes and promotes translation in the cytoplasm. METTL3 depletion inhibits translation, and both wild-type and catalytically inactive METTL3 promote translation when tethered to a reporter mRNA. Mechanistically, METTL3 enhances mRNA translation through an interaction with the translation initiation machinery. METTL3 expression is elevated in lung adenocarcinoma and using both loss- and gain-of-function studies, we find that METTL3 promotes growth, survival, and invasion of human lung cancer cells. Our results uncover an important role of METTL3 in promoting translation of oncogenes in human lung cancer.
Keywords : METTL3, N6-methyladenosine, m6A, translation, EGFR, ribosome, cancer
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기